Metabolic dysfunction-associated steatotic liver disease (MASLD) and alcoholic liver disease (ALD) are drivers of liver cancer, promoting its development through chronic liver injury and inflammation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results